Most Viewed Articles from NEJM

ALL#A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A Possible Role for Anti-idiotype Antibodies in SARS-CoV-2 Infection and Vaccination

Wednesday, November 24, 2021 - 7:00 AM

Early Convalescent Plasma for High-Risk Outpatients with Covid-19

Wednesday, November 17, 2021 - 5:00 PM

Covid-19 Vaccination during Pregnancy and First-Trimester Miscarriage

Wednesday, November 17, 2021 - 5:00 PM

Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab

Wednesday, November 17, 2021 - 5:00 PM

Insights into Salt Handling and Blood Pressure

Wednesday, November 17, 2021 - 5:00 PM

The Future of SARS-CoV-2 Vaccination — Lessons from Influenza

Wednesday, November 10, 2021 - 5:00 PM

Ocular Findings in the Sturge–Weber Syndrome

Wednesday, November 10, 2021 - 5:00 PM

100,000 Genomes Pilot on Rare-Disease Diagnosis in Health Care — Preliminary Report

Wednesday, November 10, 2021 - 5:00 PM

Angiotensin Receptor–Neprilysin Inhibition in Acute Myocardial Infarction

Wednesday, November 10, 2021 - 5:00 PM

Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant

Wednesday, November 10, 2021 - 7:00 AM

To the Editor: In their study, Lopez Bernal et al. (Aug. 12 issue)1 estimate the effectiveness of the BNT162b2 and ChAdOx1 nCoV-19 vaccines against symptomatic disease caused by the B.1.617.2 (delta) variant. The authors encountered a unique